This volume brings together updated fundamental knowledge of the schistosomes, their biology and epidemiology, the mechanism of disease and a full description of the pathological sequelae and clinical syndromes in humans. It concludes with chapters on diagnosis and treatment prospects of vaccine development and the most significant controversies regarding immunology and epidemiology. Contents: Schistosomiasis: Setting the Stage (A AF Mahmoud); The Schistosomes and Their Intermediate Hosts (R F Sturrock); The Structure and Expression of the Schistosome Genome (G R Franco & A JG Simpson); Epidemiology of Schistosomiasis: Determinants of Transmission of Infection (C H King); Resistance to Infection in Humans and Animal Models (D Dunne & A Mountford); Initiation and Regulation of Disease in Schistosomiasis (C L King); Disease in Schistosomiasis Haematobia (C H King); Disease in Schistosomiasis Mansoni in Brazil (A Prata); Disease in Schistosomiasis Mansoni in Africa (J Ouma et al.); Disease in Schistosomiasis Japonica (R M Olveda); Disease Due to Schistosoma mekongi, S intercalatum and Other Schistosome Species (C H King); Strategies for Control of Infection and Disease: Current Practice and Future Potential (R Bergquist); Progress in Vaccine Development (S L James & D G Colley); Immunology of Schistosomiasis: Towards a Consensus Viewpoint (A Sher & A AF Mahmoud). Readership: Undergraduates and researchers in immunology, clinical methods/lab medicine, and tropical medicine and hygiene.
Physicians in most developed countries are at a great disadvantage when confronted with geographic and tropical diseases. They may be faced with prevention for patients who are outward bound or with diagnosis and treatment on their return. The practitioners' difficulties relate to inade quate teaching in medical schools and to the infrequency with which they are confronted with these exotic diseases. It is quite surprising to realize the extent of travel by Americans to areas where the tropical diseases abound: in 1979 there were 3 million trips by U. S. residents to Central and South America and almost 1 million to Africa and Asia. I Further, the influx from the tropics to the United States in 1978 involved 4. 5 million visitors and more than half a million immigrants. I The single most danger ous ofthese infections is malaria, which is now averaging about 500 cases yearly in the United States; it is important to realize that infection with one species of this organism (Plasmodium falciparum) can be lethal within a few days of the onset of fever. Highly contagious infections such as the newly discovered and extremely lethal Lassa and Ebola fevers may be imported to our shores, plus cholera, antibiotic-resistant bacillary dys entery, and amebic dysentery and liver abscess. Chronic worm infections such as schistosomiasis, although rarely lethal, may have severe conse 2 quences such as paraplegia or hematemesis.
In the wake of September 11th and recent anthrax events, our nation's bioterrorism response capability has become an imminent priority for policymakers, researchers, public health officials, academia, and the private sector. In a three-day workshop, convened by the Institute of Medicine's Forum on Emerging Infections, experts from each of these communities came together to identify, clarify, and prioritize the next steps that need to be taken in order to prepare and strengthen bioterrorism response capabilities. From the discussions, it became clear that of utmost urgency is the need to cast the issue of a response in an appropriate framework in order to attract the attention of Congress and the public in order to garner sufficient and sustainable support for such initiatives. No matter how the issue is cast, numerous workshop participants agreed that there are many gaps in the public health infrastructure and countermeasure capabilities that must be prioritized and addressed in order to assure a rapid and effective response to another bioterrorist attack.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.